InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities

SCHLIEREN, Switzerland & SAN DIEGO–(BUSINESS WIRE)– #Imaging–InSphero AG, a global leader in advanced 3D in vitro models and services for drug safety and efficacy testing, today announced the acquisition of PhenoVista Biosciences, Inc., a premier provider of high-content imaging and phenotypic assay technologies based in San Diego, California. The acquisition marks an important new chapter for PhenoVista Biosciences, enabling the company to significantly expand its scientific and commercial impact by c
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks